Free Trial
NASDAQ:TIL

Instil Bio 3/4/2025 Earnings Report

Instil Bio logo
$14.48 +1.87 (+14.83%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$13.86 -0.62 (-4.29%)
As of 05/2/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Instil Bio EPS Results

Actual EPS
-$1.82
Consensus EPS
-$3.75
Beat/Miss
Beat by +$1.93
One Year Ago EPS
N/A

Instil Bio Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Instil Bio Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Instil Bio's next earnings date is estimated for Friday, May 9, 2025, based on past reporting schedules.

Conference Call Resources

Instil Bio Earnings Headlines

Instil Bio reports Q4 adjusted EPS ($1.08) vs. ($1.26) last year
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Instil Bio: Time To Hop On The Summit Wave?
JMP Securities Keeps Their Hold Rating on Instil Bio (TIL)
See More Instil Bio Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Instil Bio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Instil Bio and other key companies, straight to your email.

About Instil Bio

Instil Bio (NASDAQ:TIL), a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

View Instil Bio Profile

More Earnings Resources from MarketBeat